"Mothers and daughters should share many things. Chemotherapy isn't
one of them."
- Cancer Victim
MONTREAL, Oct. 10 /CNW Telbec/ - Imagine being told that you carry a gene
that drastically increases your risk of developing breast or ovarian cancer
over your lifetime, and that you have a 50% chance of passing that gene on to
your children. What would you do?
This is the question women are facing now since the discovery of the
BRCA 1 and 2 mutations in 1994. Women carrying these mutations have, in the
absence of risk reducing strategies, up to a ninety percent life time risk of
developing breast cancer and a forty percent life time risk of developing
ovarian cancer. As for "What to do?" - many are opting for prophylactic
mastectomies and oophorectomies (preventative removal of the breasts and
Joanne Miller-Eisman, co-founder of the Hereditary Breast and Ovarian
Cancer Foundation (HBOC), wants to help women identify their risk and push for
better solutions for mutation carriers: "When I first found out I had the
gene, the first thing I could think of was my children - especially my
daughter. I hope that they have better options than I had." To this end, HBOC
has organized, in collaboration with the McGill Programme in Cancer Genetics,
a Free Public Information Evening on Hereditary Breast and Ovarian Cancer
featuring world leaders in BRCA research and clinical care.
The Evening will cover the psychological impact to the patient and her
family on being diagnosed as a gene carrier. Approximately 200 people are
expected to attend.
Helping you and your loved ones deal with the hand you are dealt
Wednesday, October 17, 2007 - 7 p.m. to 9 p.m.
Hotel Delta Montréal, 475 President Kennedy West, Montréal
The public is urged to reserve in advance by calling (514) 481-7408 x 230
or by sending an email to firstname.lastname@example.org by October 15, 2007.
This evening coincides with a ground-breaking 3 day academic symposium
entitled "BRCA - New Frontiers in Research and Practice" to be held
October 17-19, 2007 at the Hotel Delta Montréal. Researchers and clinicians
will be exchanging cutting-edge developments and best-practices for dealing
with BRCA 1 and 2. More information on both the free public evening and the
symposium are available online at www.odon.ca/brca
For further information:
For further information: April O'Donoughue, O'Donoughue & Associates
Event Management Ltd., (450) 292-3456, (514) 481-7408 ext. 228, Cellular: